Traditional Chinese medicine composition for treating chronic renal insufficiency and preparation method thereof

Through the traditional Chinese medicine composition of "Shenqi Qinghua Prescription", the chronic renal insufficiency of liver and kidney deficiency and stasis blocking of turbidity was solved by using the effects of nourishing yin and suppressing yang, promoting blood circulation and promoting menstruation, detoxifying and promoting dampness of the Chinese medicine composition. The problem of poor efficacy of the prior art has achieved improvement in renal function and reduced creatinine levels in patients, while improving the convenience of carrying and shelf life of the drug through granules.

CN118948991APending Publication Date: 2024-11-15SHANGHAI SEVENTH PEOPLES HOSPITAL
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411307437.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-19
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing technology has poor efficacy in treating chronic renal insufficiency, especially for patients with liver and kidney yin deficiency and turbidity blocking. There is a lack of effective traditional Chinese medicine prescriptions and treatment methods. After the glomerular filtration rate decreases, traditional medicines The effect is poor, and alternative treatments such as kidney transplantation are scarce, expensive and have many complications.

Method used

A Chinese medicine composition 'Ginseng and Astragalus Qinghua Recipe' is proposed, which consists of genus ginseng, astragalus, Rehmannia glutinosa, Cornus officinalis, Yam, Wangbuli, Curcuma zedoaria, wild yam, wild yam, snake tongue, summer truncao, corn squid, tortoise shell, and dans , red peony root, orally taken in decoction or granules, combined with traditional Chinese medicine theory to treat the pathological mechanism of liver and kidney yin deficiency and turbidity blockage.

Benefits of technology

Significantly reduce the creatinine level of patients with kidney failure with liver and kidney yin deficiency and turbidity blockage, improve renal function, and fill the gap in the treatment of liver and kidney disease. The traditional decoction method has short shelf life and inconvenient portability Resolved by preparing pellet form.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention provides a traditional Chinese medicine composition for treating chronic renal insufficiency. The traditional Chinese medicine composition for treating chronic renal insufficiency is prepared from the following traditional Chinese medicine raw materials in parts by weight: 15-30 parts of radix pseudostellariae, 15-30 parts of astragalus membranaceus, 15-30 parts of rehmannia, 15-30 parts of dogwood, 15-30 parts of Chinese yam, 30-60 parts of cowherb seed, 15-30 parts of curcuma zedoary, 15-30 parts of rhizoma smilacis glabrae, 30-60 parts of hedyotis diffusa, 10-20 parts of selfheal, 15-30 parts of corn stigma, 10-20 parts of tortoise shell, 15-30 parts of cortex moutan and 15-30 parts of red paeony root. The traditional Chinese medicine composition for treating the chronic renal insufficiency is named as a Shenqi Qingshui prescription, can be prepared into traditional Chinese medicine decoction for taking in clinical treatment, and can also be prepared into Shenqi Qingshui granules for oral taking together with other auxiliary materials, and the invention further provides a preparation method of the Shenqi Qingshui granules. The traditional Chinese medicine composition disclosed by the invention can effectively reduce the creatinine level of renal failure patients with deficiency of liver-yin and kidney-yin and stagnation of blood stasis and improve the renal function when being applied clinically.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating chronic renal insufficiency and a preparation method thereof. Background Art

[0002] Chronic kidney disease (CKD) has a high prevalence and low awareness. A cross-sectional epidemiological study in my country showed that the incidence of CKD in people over 18 years old is 10.8%. Once CKD progresses to renal insufficiency, it may soon develop into renal failure if no intervention is given. Currently, there is no specific drug to treat renal insufficiency. In terms of treatment, the primary disease (such as lupus, chronic nephritis, diabetes, hypertension, etc.) is often controlled and treated, and measures such as low-protein diet, adjusting work and rest, and avoiding infection inducements are used to delay the progression of renal failure. At present, ACEI / ARB drugs are still recognized as having a definite effect, but the actual effect in clinical application is still unsatisfactory. In recent years, drugs such as SGLT2, Nosinto, and Finerenone have also been proven to have a certain effect on protecting the kidneys, but large samples and long-term clinical verification are still needed. Moreover, whether it is traditional ACEI / ARB or recent SGLT2, Nosinto, Finerenone and other drugs, once the glomerular filtration rate drops to a certain level, they also need to be used with caution or disabled. Patients with late-stage renal failure can only receive renal replacement therapies such as kidney transplantation, hemodialysis, and peritoneal dialysis, but such treatments have disadvantages such as scarce kidney sources, high prices, and many complications.

[0003] Traditional Chinese medicine is a treasure of the motherland. It has been proven that it can delay the progression of renal failure. It can be treated by different prescriptions for different syndromes, stages, and different glomerular filtration rates. As for the pathogenesis of renal insufficiency, the Chinese medicine community currently recognizes that this disease is a syndrome of deficiency of the root and excess of the symptoms. The deficiency of the root is mainly spleen and kidney deficiency, and the excess of the symptoms is mainly the stagnation of pathological products such as water, dampness, heat, blood stasis, and toxins, which leads to a series of symptoms of renal failure such as nausea, vomiting, edema, asthma, oliguria, etc.

[0004] In long-term clinical practice, it is found that liver and kidney yin deficiency is another type of disease besides spleen and kidney deficiency in renal failure, and it is often overlooked. The theoretical basis of liver and kidney yin deficiency in renal failure comes from the liver and kidney homology in traditional Chinese medicine. In renal failure, kidney essence is deficient and water cannot contain wood, resulting in insufficient liver yin and hyperactivity of virtual yang. Clinically, renal hypertension can be seen, and the syndrome includes red tongue, yellow fur, stringy liver pulse, flushed face, etc.; long-term kidney yin deficiency damages yang qi, qi transformation function is abnormal, bladder opening and closing are dysfunctional, water and dampness are retained inside, turbid toxins are stagnant, and clinically, nausea, vomiting, edema, etc.; liver fails to release, fluid distribution is dysfunctional, and dampness and turbidity in the triple burner are retained, clinically, abdominal distension, poor appetite, hiccups, etc.; internal accumulation of turbid toxins blocks the qi mechanism, blocks the kidney meridians, and generates internal blood stasis, or long-term illness with turbid toxins consumes vital energy, qi cannot flow through blood, and blood stagnates in the meridians, and the liver's release function is abnormal, meridians are blocked, blood circulation is poor, which also leads to blood stasis, and clinically, edema is difficult to eliminate, dark tongue, and varicose veins under the tongue, etc.

[0005] However, there are not many scholars who treat renal failure from the perspective of liver and kidney, and there are also few prescriptions that use the liver and kidney as the basis for treatment. Summary of the invention

[0006] The technical problem to be solved by the present invention is to provide a Chinese medicine composition for treating chronic renal insufficiency and a preparation method thereof in view of the deficiencies of the above-mentioned prior art. In clinical studies, we found that liver and kidney deficiency, especially liver and kidney yin deficiency, is not uncommon in the deficiency syndrome of renal failure, and the symptoms of renal failure patients of this syndrome are often dominated by blood stasis, water dampness, turbidity and toxicity. The age distribution of such patients has certain characteristics. Most of the main populations are older. If they are in their prime, they may have a high work pressure or eat more rich and greasy food. The elderly are due to insufficient kidney essence, and most of the middle-aged people are due to worrying, secretly depleting essence and blood, or emotional frustration, and injuring yin with fire, which leads to kidney yin deficiency, yin does not control yang, liver yang rises, and liver and kidney yin deficiency syndrome occurs. The clinical tongue and pulse manifestations are mostly red tongue, yellow fur and stringy pulse. Kidney essence is depleted, water does not contain wood, yang hyperactivity turns into wind, liver yin is insufficient, liver wind moves internally, and clinical common personality is irritable, dizziness and even headache. Wind is active and moves, sneaks into the kidney network, the kidney loses its seal, and the essence leaks out, and proteinuria is seen clinically. Liver and kidney deficiency, after a long time, the essence is damaged and there is no way to transform qi, qi deficiency has no way to produce blood, and the qi and blood are not smooth and cause blood stasis syndrome. The kidney is a water organ, kidney qi deficiency, water metabolism disorder, turbid toxins are internally contained and cannot be taken out, and blood stasis and dampness, turbid toxins are intertwined, clinical common oliguria, edema is difficult to eliminate, and metabolite indicators such as creatinine are delayed. Therefore, based on the diagnosis and treatment of renal failure (chronic renal insufficiency) in more than 30 years, the present invention proposes an empirical prescription for treating liver and kidney yin deficiency, turbid blood stasis and chronic renal insufficiency-Shenqi Qinghua Fang, which is applied to clinically effectively reduce the creatinine level of renal failure patients with liver and kidney yin deficiency and turbid blood stasis, and improve renal function.

[0007] In order to solve the above technical problems, the technical solution adopted by the present invention is:

[0008] A traditional Chinese medicine composition for treating chronic renal insufficiency is prepared from the following traditional Chinese medicine raw materials in parts by weight: 15-30 parts of Pseudostellariae Radix, 15-30 parts of Astragalus, 15-30 parts of Rehmannia glutinosa, 15-30 parts of Cornus officinalis, 15-30 parts of Dioscorea opposita, 30-60 parts of Vaccaria segetalis, 15-30 parts of Curcuma, 15-30 parts of Smilax glabra, 30-60 parts of Hedyotis diffusa, 10-20 parts of Prunella vulgaris, 15-30 parts of Cornus officinalis, 10-20 parts of Tortoise Shell, 15-30 parts of Moutan Cortex, and 15-30 parts of Red Peony Root.

[0009] Preferably, the Chinese medicine composition for treating chronic renal insufficiency is made of the following Chinese medicine raw materials in parts by weight: 15 parts of Pseudostellariae Radix, 15 parts of Astragalus, 15 parts of Rehmannia glutinosa, 15 parts of Cornus officinalis, 15 parts of Dioscorea opposita, 30 parts of Vaccaria segetalis, 15 parts of Curcuma, 15 parts of Smilax glabra, 30 parts of Hedyotis diffusa, 10 parts of Prunella vulgaris, 15 parts of Corn silk, 10 parts of Tortoise Shell, 15 parts of Moutan Cortex, and 15 parts of Red Peony Root.

[0010] Preferably, the Chinese medicine composition for treating chronic renal insufficiency is named Shenqi Qinghua Recipe, which can be made into a Chinese medicine decoction for oral administration in clinical treatment, or can be made into Shenqi Qinghua granules with other auxiliary materials for oral administration.

[0011] The present invention also provides a method for preparing the Shenqi Qinghua granules, which comprises the following steps:

[0012] S1. Extraction:

[0013] S101, taking one-third of the tortoise shells, crushing them to 140-200 mesh, sterilizing them, and obtaining tortoise shell powder; crushing the other two-thirds of the tortoise shells to 80-100 mesh, immersing them in purified water, boiling them 3 times, each time for 1.5 hours, filtering, combining the extracts, and concentrating them to a volume of 10% to obtain tortoise shell extract; adding the tortoise shell powder to the tortoise shell extract, stirring evenly, drying, and crushing them to 120-140 mesh to obtain tortoise shell powder;

[0014] S102, put Pseudostellariae Radix, Astragalus, Rehmannia glutinosa, Cornus officinalis, Dioscorea opposita, Vaccaria segetalis, Curcuma zedoaria, Smilax glabra, Hedyotis diffusa, Prunella vulgaris, Cornus officinalis, Cortex Moutan and Paeonia lactiflora into the medicine pot, decoct for 3 times, filter, combine the extracts, add the tortoise shell powder obtained in S101, and then concentrate the extracts to a drug-liquid ratio of 1:2, centrifuge, and concentrate to a relative density of 1.14-1.15 at 75-85°C to obtain a water extract;

[0015] S2, mixing, drying, crushing

[0016] The water extract obtained in S1, dextrin and ethanol are fully mixed, and then vacuum dried to obtain a dry extract; the dry extract is crushed and passed through an 80-mesh sieve to obtain a powder;

[0017] S3, granulation

[0018] The powder obtained in S2 is put into a one-step granulator, and the air inlet is turned on to make the powder boil evenly in the tank, and the material temperature is heated to 35-45°C, and the air inlet temperature does not exceed 65°C; 10% starch slurry is sprayed in for granulation, and the material is discharged after mixing, and the granules are shaped;

[0019] S4. Packaging

[0020] Packed in bags of 15g each.

[0021] Preferably, the drying in S101 is spray drying, and the inlet air temperature is set at 135-165°C, the outlet air temperature is set at 90-110°C, the pressure in the tower is -0.1-0.6 kPa, and the wall temperature is <45°C.

[0022] Preferably, in the three decoctions in S102, the first decoction is made of medicinal material: water = 1:4 (w / v), and the decoction is performed for 1.5 hours; the second decoction is made of medicinal material: water = 1:3 (w / v), and the decoction is performed for 1 hour; and the third decoction is made of medicinal material: water = 1:2 (w / v), and the decoction is performed for 0.5 hours.

[0023] Preferably, the mass fraction of the ethanol in S2 is 75%, and the usage ratio of the water extract, dextrin and ethanol is 1:2:2.

[0024] Preferably, the vacuum drying conditions in S2 are drying temperature of 60° C., vacuum degree of -0.1 MPa, and drying time of 2.5 to 3 h.

[0025] Preferably, the ratio of the powder in S3 to the 10% starch slurry is 1:1.5.

[0026] In the Shenqi Qinghua prescription of the present invention, mainly adopt Radix Pseudostellariae, Radix Astragali, Fructus Corni, Rhizoma Dioscoreae to nourish qi and yin, tonify liver and invigorate kidney, renal failure is the card of deficiency in the root and excess in the superficial, need to be cautious when adopting tonic medicine, mainly with flat tonic, avoid strong tonic, strong tonic can produce the drawback of keeping the enemy behind closed doors, cause poison evil to accumulate, nowhere to excrete, clinically because strong tonic causes creatinine to rise not a minority, Radix Pseudostellariae, Radix Astragali, Fructus Corni, Rhizoma Dioscoreae four flavor medicines are flat tonic medicine, without the drawback of strong tonic. Simultaneously because renal failure often has a long course of disease, liver and kidney yin deficiency, virtual yang rises for a long time, common nourishing yin and suppressing yang medicine has not reached the effect, for this, this party specially adopts tortoise shell, its effect is better than general nourishing yin medicine, is equipped with Herba Prunellae to clear liver and purge fire simultaneously, Stigma Corni suppresses liver and promotes diuresis, while strengthening the nourishing yin effect, suppresses the virtual yang, clears away heat and purges fire, better plays the effect of nourishing yin and suppressing yang. At the same time, another characteristic of this syndrome is blood stasis. This type of blood stasis is different from general blood stasis. It is together with water accumulation, heat accumulation and poison accumulation, and is the main factor leading to the continuous progression of renal failure and its difficulty in control. Ordinary blood circulation and blood stasis removal effects are poor. This prescription uses fenugreek and curcuma to break up blood and promote qi circulation, while tortoise shell has the effect of softening and dispersing nodules. The combination of the three medicines enhances the effectiveness of blood circulation, while moutan bark, red peony root and rehmannia root are used to clear away heat and cool blood, while smilax glabra and snake tongue grass are used to detoxify and remove dampness, and to remove stagnant water, heat and poison.

[0027] The present invention has the following significant technical effects:

[0028] 1. The present invention provides a Chinese medicine composition for treating chronic renal insufficiency, namely, Shenqi Qinghua Fang, which is an empirical prescription for treating chronic renal insufficiency caused by liver-kidney yin deficiency and turbid blood stasis, and is composed of 14 medicinal materials, including Pseudostellaria sutchuenensis, Astragalus membranaceus, Rehmannia glutinosa, Cornus officinalis, Dioscorea opposita, Vaccaria segetalis, Curcuma zedoaria, Smilax glabra, Hedyotis diffusa, Prunella vulgaris, Cornus officinalis, Tortoise shell, Cortex Moutan and Red Peony Root. In the formula, Pseudostellaria baicalensis and Astragalus membranaceus are the main medicines for invigorating qi and nourishing yin, Cornus officinalis nourishes the liver and kidneys, Chinese yam strengthens the spleen and kidneys, and tortoise shell nourishes yin and suppresses yang, which are the assistant medicines. Herba Prunellae can clear the liver and purge fire, Corn silk can calm the liver and promote diuresis, Cortex Moutan, Red Peony Root and Rehmannia Glutinosa can clear heat and cool blood, Vaccariae Vaccariae can promote blood circulation and unblock the menstruation, and Curcuma zedoaria can break up blood circulation and promote qi circulation, further increasing the effect of promoting blood circulation, while Smilax glabra and Herba Hedyotis diffusae can detoxify and eliminate dampness. The whole formula nourishes yin, nourishes the kidneys and calms the liver, clears heat, activates blood circulation and eliminates turbidity, and is used to treat chronic renal failure with liver and kidney yin deficiency and blood stasis and turbidity blockage. It has significant clinical efficacy and is an effective prescription for treating renal failure with liver and kidney yin deficiency and blood stasis and turbidity blockage, filling the gap in the treatment of this type of renal failure. In particular, tortoise shell is used in the prescription. This medicine is different from general yin-nourishing medicines. It nourishes yin and suppresses yang, and is particularly suitable for liver and kidney yin deficiency and hyperactivity of virtual yang. It also has the effect of softening and dispersing nodules. The recognized pathological structure of renal failure is renal tissue fibrosis, which is considered by traditional Chinese medicine to be a sign of blood stasis. However, due to its long course of disease and stubborn blood stasis, general blood-activating and stasis-removing medicines have poor effects. Turtle shell softens and disperses nodules, and has a stronger blood-activating effect after cooperating with fenugreek and curcuma, and is more suitable for chronic renal failure. The Shenqi Qinghua prescription of the present invention has a special compatibility, which is different from general liver and kidney nourishing, blood-activating and turbidity-removing prescriptions. It is applied clinically to effectively reduce the creatinine level of renal failure patients with liver and kidney yin deficiency and turbidity stagnation, and improve renal function.

[0029] 2. The clinical efficacy of the Shenqi Qinghua prescription of the present invention is remarkable, but the traditional decoction method has a short shelf life, poor taste, and is inconvenient to carry. In particular, the important ministerial drug component tortoise shell of the composition of this prescription is hard in texture, and the effective ingredients are difficult to fry out. The traditional decoction adopts first frying, and the quality is difficult to control. Therefore, in addition to being made into a Chinese medicine decoction for taking in clinical treatment, the Shenqi Qinghua prescription of the present invention can also be made into Shenqi Qinghua granules for oral administration. The present invention also provides a preparation method of Shenqi Qinghua granules, which uses the techniques of crushing and extracting tortoise shells to treat tortoise shells in advance, retains its effective ingredients to the maximum extent, and then cooperates with other drugs to prepare Shenqi Qinghua granules through the techniques of concentrating, extracting, mixing, drying, crushing, etc., which is convenient to carry and take, and expands the user population of Shenqi Qinghua prescription.

[0030] The present invention is further described in detail below in conjunction with embodiments. DETAILED DESCRIPTION

[0031] Example 1

[0032] This embodiment is a Chinese medicine composition for treating chronic renal insufficiency, which is made of the following Chinese medicine raw materials in parts by weight: 15 parts of Pseudostellariae Radix, 15 parts of Astragalus, 15 parts of Rehmannia glutinosa, 15 parts of Cornus officinalis, 15 parts of Dioscorea opposita, 30 parts of Vaccaria segetalis, 15 parts of Curcuma, 15 parts of Smilax glabra, 30 parts of Hedyotis diffusa, 10 parts of Prunella vulgaris, 15 parts of Corn silk, 10 parts of Carapax tortoise shell, 15 parts of Cortex Moutan, and 15 parts of Red Peony Root.

[0033] The Chinese medicine composition for treating chronic renal insufficiency of the present invention is named Shenqi Qinghua Recipe, which can be prepared into a Chinese medicine decoction for oral administration in clinical treatment, or can be prepared into Shenqi Qinghua granules with other auxiliary materials for oral administration.

[0034] The preparation method of Shenqi Qinghua Granules comprises the following steps:

[0035] S1. Extraction:

[0036] S101, taking one-third of the tortoise shells, crushing them to 140-200 mesh, sterilizing them, and obtaining tortoise shell powder; crushing the other two-thirds of the tortoise shells to 80-100 mesh, immersing them in pure water, boiling them 3 times, each time for 1.5 hours, filtering, combining the extracts, and concentrating them to a volume of 10% to obtain tortoise shell extract; adding the tortoise shell powder to the tortoise shell extract, stirring evenly, spray drying, setting the inlet air temperature to 135-165°C, the outlet air temperature to 90-110°C, the tower pressure to -0.1-0.6 kPa, the wall protection temperature <45°C, and crushing them to 120-140 mesh after drying to obtain tortoise shell powder;

[0037] S102, put Pseudostellariae Radix, Astragalus, Rehmannia glutinosa, Cornus officinalis, Chinese yam, Vaccaria segetalis, Curcuma zedoaria, Smilax glabra, Hedyotis diffusa, Prunella vulgaris, Corn silk, Cortex Moutan, and Paeonia lactiflora into the medicine pot, and boil for 3 times, the first time the medicine: water = 1:4 (w / v), boil for 1.5 hours; the second time the medicine: water = 1:3 (w / v), boil for 1 hour; the third time the medicine: water = 1:2 (w / v), boil for 0.5 hours, filter, combine the extracts, add the tortoise shell powder obtained in S101, and then concentrate the extract to a drug-liquid ratio of 1:2, centrifuge, and concentrate to a relative density of 1.14-1.15 at 75-85°C to obtain a water extract;

[0038] S2, mixing, drying, crushing

[0039] The water extract obtained in S1, dextrin and 75% ethanol by mass are fully mixed in a dosage ratio of 1:2:2, and then vacuum dried at a drying temperature of 60°C, a vacuum degree of -0.1MPa, and a drying time of 2.5 to 3h to obtain a dry extract; the dry extract is crushed and passed through an 80-mesh sieve to obtain a powder;

[0040] S3, granulation

[0041] The powder obtained in S2 is put into a one-step granulator, and the air inlet is turned on to make the powder boil evenly in the tank, and the material temperature is heated to 35-45°C, and the air inlet temperature does not exceed 65°C; 10% starch slurry is sprayed in for granulation, and the material is discharged after mixing, and the granules are granulated; the ratio of powder to 10% starch slurry is 1:1.5;

[0042] S4. Packaging

[0043] Packed in bags of 15g each.

[0044] Example 2

[0045] The present embodiment is a Chinese medicine composition for treating chronic renal insufficiency, which is prepared from the following Chinese medicine raw materials in parts by weight: 30 parts of Pseudostellariae Radix, 20 parts of Astragalus, 20 parts of Rehmannia glutinosa, 15 parts of Cornus officinalis, 30 parts of Dioscorea opposita, 30 parts of Vaccaria segetalis, 20 parts of Curcuma, 30 parts of Smilax glabra, 60 parts of Hedyotis diffusa, 20 parts of Prunella vulgaris, 25 parts of Corn silk, 15 parts of Carapax tortoise shell, 20 parts of Cortex Moutan, and 30 parts of Red Peony Root.

[0046] The preparation method and administration method are the same as those in Example 1.

[0047] Example 3

[0048] This embodiment is a Chinese medicine composition for treating chronic renal insufficiency, which is made of the following Chinese medicine raw materials in parts by weight: 20 parts of Pseudostellariae Radix, 15 parts of Astragalus, 30 parts of Rehmannia glutinosa, 30 parts of Cornus officinalis, 30 parts of Dioscorea opposita, 60 parts of Vaccaria segetalis, 20 parts of Curcuma, 30 parts of Smilax glabra, 40 parts of Hedyotis diffusa, 15 parts of Prunella vulgaris, 30 parts of Cornus officinalis, 20 parts of Carapax tortoise shell, 30 parts of Cortex Moutan, and 20 parts of Red Peony Root.

[0049] The preparation method and administration method are the same as those in Example 1.

[0050] Example 4

[0051] The present embodiment is a Chinese medicine composition for treating chronic renal insufficiency, which is prepared from the following Chinese medicine raw materials in parts by weight: 15 parts of Pseudostellariae Radix, 30 parts of Astragalus, 15 parts of Rehmannia glutinosa, 15 parts of Cornus officinalis, 15 parts of Dioscorea opposita, 45 parts of Vaccaria segetalis, 30 parts of Curcuma, 15 parts of Smilax glabra, 30 parts of Hedyotis diffusa, 20 parts of Prunella vulgaris, 15 parts of Cornus officinalis, 10 parts of Carapax tortoise shell, 15 parts of Cortex Moutan, and 15 parts of Red Peony Root.

[0052] The preparation method and administration method are the same as those in Example 1.

[0053] Example 5

[0054] This example is an observation of the clinical efficacy of a Chinese medicine composition for treating chronic renal insufficiency:

[0055] (1) Research subjects: A total of 50 patients who visited the outpatient and inpatient departments of the Nephrology Department of Shanghai Seventh People's Hospital between March 2022 and January 2024 were selected, including 13 cases of chronic nephritis, 17 cases of hypertensive nephropathy, 15 cases of diabetic nephropathy, and 5 cases of gouty nephropathy. They were randomly divided into 2 groups, 25 cases in each group. The control group had 11 males and 14 females with an average age of 62.08±5.3 years old, and the treatment group had 17 males and 8 females with an average age of 61.32±5.9 years old. There was no statistical difference in age between the two groups (P>0.05).

[0056] (2) Diagnostic criteria

[0057] Western medicine diagnostic criteria: Based on the "Guidelines for Monitoring and Prevention of Chronic Kidney Disease Progression" (K / DOQI) proposed by the American Kidney Foundation in 2002: (1) A history of primary chronic kidney disease or a history of other systemic diseases involving the kidneys; (2) Physical and chemical indicators of kidney damage: abnormal blood, urine, renal function components or abnormal imaging examinations for 3 months, or GFR <60ml / min / 1.73m 2 (3) Patients with CKD stage 3-4 (GFR 15-59 ml / min / 1.73 m 2 ). TCM diagnostic criteria: in line with the "Guidelines for Clinical Research of New Chinese Medicines" promulgated in 2002, liver and kidney yin deficiency, blood stasis and stagnation syndrome.

[0058] Exclusion criteria: patients aged <18 years, or >80 years; pregnant or lactating women; patients with serious primary heart, liver, lung, intestinal, blood or serious diseases that affect their survival; various infections within one month, or blood pressure and blood sugar that are difficult to control with oral medications; patients with severe complications such as anemia, acid-base imbalance and water and electrolyte disorders; patients with allergic constitution or participating in clinical trials of other drugs.

[0059] (3) Treatment options

[0060] Conventional treatment: (1) Diet therapy: high-quality low-protein (0.8-1.0 g / kg / d), low sodium (<6 g / d), and low-fat (cholesterol intake less than 200 mg / d); (2) Antihypertensive therapy: rational use of ACEI, ARB, CCB, α, β receptor antagonists, diuretics and central antihypertensive drugs to control the patient's blood pressure below 130 / 80 mmHg; (3) Hypoglycemic therapy: use repaglinide or insulin treatment to control fasting blood sugar at around 6-8 mmol / l, postprandial blood sugar at around 8-10 mmol / l, and glycated hemoglobin between 6-8%; (4) Symptomatic treatment: correct anemia, calcium-phosphorus metabolism disorders, and maintain water, electrolyte and acid-base balance.

[0061] Control group: On the basis of conventional treatment, patients were given Shenshuaining Capsule (Yunnan Leiyunshang Ideal Pharmaceutical Co., Ltd., 4 capsules / time, 3 times / day) combined with Jinshuibao Capsule (Jiangxi Jinshuibao Pharmaceutical Co., Ltd., 4 capsules / time, 3 times / day).

[0062] Treatment group: On the basis of conventional treatment, patients were given Shenqi Qinghua prescription (Pseudostellariae Pseudostellariae 15g, Astragalus 15g, Rehmannia Glutinosa 15g, Cornus Officinalis 15g, Dioscorea Opposita 15g, Vaccaria Semen 30g, Curcuma 15g, Smilax glabra 15g, Hedyotis diffusa 30g, Prunella Vulgaris 10g, Cornus officinalis 15g, Carapax Trichosanthis 10g, Cortex Moutan 15g, Paeonia lactiflora 15g), which was prepared into Chinese medicine decoction by automated standard decoction produced by Shanghai Kangqiao Pharmaceuticals. The decoction was taken orally, 2 bags per day (150ml / bag), 1 bag each in the morning and evening with warm water.

[0063] (4) Treatment course: 1 month, after which serum creatinine levels will be measured.

[0064] (5) Test results

[0065] Table 1 Comparison of serum creatinine (μmol / L) ratios before and after treatment

[0066] Before treatment After treatment Control group 223.11±47.70 195.05±46.42 Treatment Group 215.07±57.56* <![CDATA[153.70±28.03 # ]]>

[0067] Before treatment, the treatment group was compared with the control group, *P>0.05, no statistical significance; after treatment, the treatment group was compared with the control group, # P<0.01, statistically significant. It is proved that the Chinese medicine composition for treating chronic renal insufficiency of the present invention can effectively reduce the creatinine level of renal failure patients with liver and kidney yin deficiency and stasis and improve renal function.

[0068] Typical Cases

[0069] Case 1

[0070] Zhang, male, 74 years old, hypertensive nephropathy, was diagnosed at the Seventh People's Hospital of Shanghai because of "creatinine elevation for more than one year." The patient has a history of hypertension for 20 years and takes telmisartan for blood pressure reduction. On December 30, 2022, creatinine was found to be 216.5μmol / L. He took Bailing Capsules and Shenshuaining Capsules for a long time. Creatinine was 169.5μmol / L on October 27, 2023, 156.2μmol / L in November 2023, and 173.4μmol / L on December 11, 2023. He visited the hospital on December 11, 2023, and reported that blood pressure control was good, with a slight dry mouth, and no other obvious discomfort. The tongue was light red with tooth marks on the edges and yellow fur. Bailing Capsules were discontinued, Shenshuaining was continued, and the Shenqi Qinghua Recipe of the present invention was given for 1 month. The method of taking is: 14 pairs, 1 dose per day, decocted in 400mL of water, 2 times per dose. The creatinine level was rechecked on January 8, 2024, and it was 135.9 μmol / L. The original prescription was continued for one month. The creatinine level was rechecked on February 5, 2024, and it was 117.8 μmol / L.

[0071] Case 2

[0072] Zhang, male, 65 years old, diabetic nephropathy, was admitted to Shanghai Seventh People's Hospital on January 31, 2024, because of "creatinine elevation for 4 years and progressive increase for more than 2 months". The patient has a history of diabetes for more than 10 years, and usually controls blood sugar with insulin. Proteinuria appeared 6 years ago, and creatinine elevation was found 4 years ago. He was then admitted to Ruijin Hospital and was advised to take Shenshuaining for a long time, and creatinine was maintained between 200-300μmol / L. The reexamination indicators in the past six months are as follows: creatinine 240.5 μmol / L in 2023.6, 274.6 μmol / L in 2023.9, 2023.10, 202.7 μmol / L in 2023.11, 248.3 μmol / L in 2024.1, and 285.3 μmol / L in 2024. Because creatinine fluctuated up and down in the past, although the overall trend was stable, creatinine has continued to rise since October 2023, and there is no downward trend. The patient came to the doctor and complained of no obvious discomfort. The tongue was light red with tooth marks on the edges, the tongue coating was thin yellow and slightly dry, and the pulse was thin. Chinese medicine diagnosis showed renal failure, qi and yin deficiency, and internal heat stagnation. The patient was advised to continue taking Shenshuai Ning, and the Shenqi Qinghua prescription of the present invention was taken for 2 weeks. The method of taking was 14 pairs, 1 dose per day, 400 mL of water decoction, 2 times each dose. On February 2024, the patient reported no obvious discomfort after taking the medicine. The creatinine level was 173.6 μmol / L, the tongue coating was slightly moist, and the rest of the tongue and pulse were the same as before. The original prescription was continued.

[0073] Case 3

[0074] Huang, male, 49 years old, chronic renal insufficiency, was treated at Shanghai Seventh People's Hospital in July 2023 because of "discovery of renal insufficiency for more than one month". The patient was hospitalized in the Department of Neurology for cerebral hemorrhage in June 2023 and was discharged after the condition stabilized. After discharge, the creatinine was found to be 205.4μmol / L, so he was treated on July 20 and was given the Shenqi Qinghua Fang of the present invention for more than half a year. The method of taking is: 14 pairs, 1 dose per day, 400mL of water decoction, 2 times per dose. During this period, only azilsartan and nifedipine controlled-release tablets were used to control blood pressure. During the period, renal function was rechecked. On August 18, 2023, the creatinine was 189μmol / L, and on April 26, 2024, the creatinine was 141.9μmol / L, and the renal function was stable.

[0075] Case 4

[0076] Huang, female, 64 years old, was treated for chronic nephritis. The patient had a history of chronic nephritis, with a long-term creatinine of about 150μmol / L. When she was treated on June 2023, her creatinine was 178.2μmol / L, and her blood pressure was 150 / 99mmHg. She was given amlodipine and benazepril to control her blood pressure, and was given the Shenqi Qinghua prescription of the present invention for six consecutive months. The method of taking the prescription was 14 packs, 1 dose per day, 400mL of water decoction, 2 doses per dose, and the prescription was not changed during the period. On December 22, 2023, the creatinine was rechecked to 140.8μmol / L, and on January 21, 2024, the creatinine was rechecked to 130.3μmol / L. The original prescription was continued, and the creatinine was stable between 130-140μmol / L.

[0077] The above is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent change made to the above embodiment according to the technical essence of the invention still falls within the protection scope of the technical solution of the present invention.

Claims

1. A Chinese medicine composition for treating chronic renal insufficiency, characterized in that: The invention is prepared from the following Chinese medicinal raw materials in parts by weight: 15-30 parts of Pseudostellariae Radix, 15-30 parts of Astragalus, 15-30 parts of Rehmannia glutinosa, 15-30 parts of Cornus officinalis, 15-30 parts of Dioscorea opposita, 30-60 parts of Vaccaria segetalis, 15-30 parts of Curcuma, 15-30 parts of Smilax glabra, 30-60 parts of Hedyotis diffusa, 10-20 parts of Prunella vulgaris, 15-30 parts of Cornus officinalis, 10-20 parts of Tortoise Shell, 15-30 parts of Moutan Cortex and 15-30 parts of Red Peony Root.

2. A Chinese medicine composition for treating chronic renal insufficiency according to claim 1, characterized in that: The Chinese medicine composition for treating chronic renal insufficiency is prepared from the following Chinese medicine raw materials in parts by weight: 15 parts of Pseudostellariae Radix, 15 parts of Astragalus, 15 parts of Rehmannia glutinosa, 15 parts of Cornus officinalis, 15 parts of Dioscorea opposita, 30 parts of Vaccaria segetalis, 15 parts of Curcuma, 15 parts of Smilax glabra, 30 parts of Hedyotis diffusa, 10 parts of Prunella vulgaris, 15 parts of Corn silk, 10 parts of Carapax tortoise shell, 15 parts of Cortex Moutan, and 15 parts of Paeonia lactiflora.

3. A Chinese medicine composition for treating chronic renal insufficiency according to claim 1 or 2, characterized in that: The Chinese medicine composition for treating chronic renal insufficiency is named Shenqi Qinghua Recipe, which can be prepared into a Chinese medicine decoction for oral administration in clinical treatment, or can be prepared into Shenqi Qinghua granules with other auxiliary materials for oral administration.

4. A method for preparing the Shenqi Qinghua granules according to claim 3, characterized in that: The following steps are involved: S1. Extraction: S101, taking one-third of the tortoise shells, crushing them to 140-200 mesh, sterilizing them, and obtaining tortoise shell powder; crushing the other two-thirds of the tortoise shells to 80-100 mesh, immersing them in purified water, boiling them 3 times, each time for 1.5 hours, filtering, combining the extracts, and concentrating them to a volume of 10% to obtain tortoise shell extract; adding the tortoise shell powder to the tortoise shell extract, stirring evenly, drying, and crushing them to 120-140 mesh to obtain tortoise shell powder; S102, put Pseudostellariae Radix, Astragalus, Rehmannia glutinosa, Cornus officinalis, Dioscorea opposita, Vaccaria segetalis, Curcuma zedoaria, Smilax glabra, Hedyotis diffusa, Prunella vulgaris, Cornus officinalis, Cortex Moutan and Paeonia lactiflora into the medicine pot, decoct for 3 times, filter, combine the extracts, add the tortoise shell powder obtained in S101, and then concentrate the extracts to a drug-liquid ratio of 1:2, centrifuge, and concentrate to a relative density of 1.14-1.15 at 75-85°C to obtain a water extract; S2, mixing, drying, crushing The water extract obtained in S1, dextrin and ethanol are fully mixed, and then vacuum dried to obtain a dry extract; the dry extract is crushed and passed through an 80-mesh sieve to obtain a powder; S3, granulation The powder obtained in S2 is put into a one-step granulator, and the air inlet is turned on to make the powder boil evenly in the tank, and the material temperature is heated to 35-45°C, and the air inlet temperature does not exceed 65°C; 10% starch slurry is sprayed in for granulation, and the material is discharged after mixing, and the granules are shaped; S4, Packaging Packed in bags of 15g each.

5. The method for preparing the Shenqi Qinghua granules according to claim 4, characterized in that: The drying described in S101 is spray drying, and the inlet air temperature is set at 135-165°C, the outlet air temperature is set at 90-110°C, the pressure in the tower is -0.1-0.6 kPa, and the wall temperature is <45°C.

6. The method for preparing the Shenqi Qinghua granules according to claim 4, characterized in that: In the three decoctions in S102, the first decoction is made of medicinal material: water = 1:4 (w / v), and the decoction is performed for 1.5 hours; the second decoction is made of medicinal material: water = 1:3 (w / v), and the decoction is performed for 1 hour; and the third decoction is made of medicinal material: water = 1:2 (w / v), and the decoction is performed for 0.5 hours.

7. The method for preparing the Shenqi Qinghua granules according to claim 4, characterized in that: The mass fraction of the ethanol in S2 is 75%, and the usage ratio of the water extract, dextrin and ethanol is 1:2:

2.

8. The method for preparing the Shenqi Qinghua granules according to claim 4, characterized in that: The vacuum drying conditions in S2 are as follows: drying temperature is 60° C., vacuum degree is -0.1 MPa, and drying time is 2.5 to 3 hours.

9. The method for preparing the Shenqi Qinghua granules according to claim 4, characterized in that: The ratio of the powder in S3 to the 10% starch slurry is 1:1.5.

Citation Information

Patent Citations

  • Composition of Chinese traditional medicine for lightening protein of urine

    CN101091768A

  • Traditional Chinese medicine composition for treating nephritis as well as preparation method and application of composition

    CN102940824A